ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,678Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1019

$870K Total Retail Price of All Prescriptions

Rank: 15 out of 1019

977 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CARVEDILOL 642 518 1 3
CLOPIDOGREL 626 551 2 7
FUROSEMIDE 596 500 3 6
DIGOXIN 539 519 4 14
METOPROLOL SUCCINATE 509 444 5 1
ISOSORBIDE MONONITRATE ER 498 446 6 12
COUMADIN 493 439 7 54
SIMVASTATIN 490 434 8 5
PLAVIX 476 406 9 11
LISINOPRIL 472 404 10 2
ATORVASTATIN CALCIUM 410 362 11 10
METOPROLOL TARTRATE 406 371 12 8
WARFARIN SODIUM 396 320 13 9
AMLODIPINE BESYLATE 382 334 14 4
AMIODARONE HCL 339 268 15 22
POTASSIUM CHLORIDE 256 216 16 15
DIOVAN 253 241 17 20
HYDROCHLOROTHIAZIDE 251 240 18 18
FAMOTIDINE 246 219 19 82
RAMIPRIL 219 196 20 21
LOSARTAN POTASSIUM 185 168 21 17
CILOSTAZOL 174 158 22 45
SPIRONOLACTONE 172 148 23 23
NITROSTAT 140 108 24 27
RANEXA 138 112 25 32
ATENOLOL 137 119 26 19
CLONIDINE HCL 133 123 27 29
PRADAXA 133 118 27 24
TRICOR 132 128 29 61
PRAVASTATIN SODIUM 123 107 30 16
CRESTOR 118 99 31 13
SOTALOL 111 111 32 35
HYDRALAZINE HCL 110 103 33 34
LEVOTHYROXINE SODIUM 107 100 34 25
VERAPAMIL ER 97 95 35 77
EFFIENT 96 80 36 53
TOPROL XL 87 83 37 101
NIASPAN 84 71 38 33
BENAZEPRIL HCL 83 83 39 69
FLUDROCORTISONE ACETATE 83 80 39 202
NIFEDIPINE ER 82 77 41 40
JANTOVEN 82 82 41 73
KLOR-CON M20 80 74 43 56
DILTIAZEM 24HR ER 74 74 44 84
TORSEMIDE 68 68 45 50
PANTOPRAZOLE SODIUM 67 61 46 46
PACERONE 64 62 47 88
MULTAQ 64 64 47 49
DILTIAZEM ER 63 51 49 79
LIPITOR 61 57 50 37
ZETIA 61 47 50 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 55 52 28
LOVASTATIN 57 57 53 44
KLOR-CON 10 52 52 54 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.